AU2392795A - Isolation and characterization of a novel primate t-cell lymphotropic virus and the use of this virus or components thereof in diagnostics assays and vaccines - Google Patents

Isolation and characterization of a novel primate t-cell lymphotropic virus and the use of this virus or components thereof in diagnostics assays and vaccines

Info

Publication number
AU2392795A
AU2392795A AU23927/95A AU2392795A AU2392795A AU 2392795 A AU2392795 A AU 2392795A AU 23927/95 A AU23927/95 A AU 23927/95A AU 2392795 A AU2392795 A AU 2392795A AU 2392795 A AU2392795 A AU 2392795A
Authority
AU
Australia
Prior art keywords
virus
vaccines
characterization
isolation
components
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU23927/95A
Other languages
English (en)
Inventor
Genoveffa Franchini
Robert C. Gallo
Adriana Giri
Phillip Markham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU2392795A publication Critical patent/AU2392795A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/14011Deltaretrovirus, e.g. bovine leukeamia virus
    • C12N2740/14021Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/14011Deltaretrovirus, e.g. bovine leukeamia virus
    • C12N2740/14022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AU23927/95A 1994-04-22 1995-04-21 Isolation and characterization of a novel primate t-cell lymphotropic virus and the use of this virus or components thereof in diagnostics assays and vaccines Abandoned AU2392795A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US231526 1988-08-12
US23152694A 1994-04-22 1994-04-22
PCT/US1995/004910 WO1995029240A1 (fr) 1994-04-22 1995-04-21 Isolement et caracterisation d'un nouveau virus simien t-lymphotrope et utilisation de ce virus ou de ses constituants dans des methodes de diagnostic et dans des vaccins

Publications (1)

Publication Number Publication Date
AU2392795A true AU2392795A (en) 1995-11-16

Family

ID=22869610

Family Applications (1)

Application Number Title Priority Date Filing Date
AU23927/95A Abandoned AU2392795A (en) 1994-04-22 1995-04-21 Isolation and characterization of a novel primate t-cell lymphotropic virus and the use of this virus or components thereof in diagnostics assays and vaccines

Country Status (2)

Country Link
AU (1) AU2392795A (fr)
WO (1) WO1995029240A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2565201B1 (fr) 2005-10-17 2014-11-26 Sloan-Kettering Institute For Cancer Research Peptides de liaison WT1 HLA de classe II et compositions et procédés comprenant ceux-ci
CA2645766A1 (fr) 2006-04-10 2007-10-25 Sloan Kettering Institute For Cancer Research Peptides wt1 immunogenes et leurs methodes d'utilisation
CN104684577B (zh) 2012-01-13 2018-05-08 纪念斯隆凯特林癌症中心 免疫原性wt-1肽及其使用方法
US10815273B2 (en) 2013-01-15 2020-10-27 Memorial Sloan Kettering Cancer Center Immunogenic WT-1 peptides and methods of use thereof
PT2945647T (pt) 2013-01-15 2020-11-26 Memorial Sloan Kettering Cancer Center Péptidos imunogénicos wt-1 e métodos de uso dos mesmos

Also Published As

Publication number Publication date
WO1995029240A1 (fr) 1995-11-02

Similar Documents

Publication Publication Date Title
AU4180596A (en) Functionalised polyorganosiloxanes and one of the processes for the preparation thereof
AU1965795A (en) Absorbent materials and preparation thereof
AU7322291A (en) Abutment for dental appliances and the like
HUP9602235A3 (en) Shaker and blender
HU9601077D0 (en) Modified polysaccharides having improved absorbent properties and process for the preparation thereof
AU4311196A (en) Shroud and cyclonic cleaning apparatus incorporating same
AU1161095A (en) Procedure and device for the assembly of the ends of opticalfibers arranged in the form of a sheet
EP0569862A3 (fr) Feuille médicale autocollante et préparation médicale.
AU6327290A (en) Conjugate fibers and formed product using the same
AU8688891A (en) Chicken anemia virus vaccine and diagnostic
IL114709A0 (en) Absorbent particles methods for the preparation thereof and absorbent devices using the same
AU3919995A (en) Process and device for the preparation of medical-quality air
AU8982391A (en) Quick and dry coupling
AU4193496A (en) Process for the preparation of microspheres and microspheres made thereby
AU4595889A (en) Gasket and medical device using the same
AU2392795A (en) Isolation and characterization of a novel primate t-cell lymphotropic virus and the use of this virus or components thereof in diagnostics assays and vaccines
HU901571D0 (en) Vaccine and diagnostics against the virus of pig-cholera
IL115272A0 (en) Asp-pallidipin pharmaceutical compositions containing the same and processes for the preparation thereof
AU3138595A (en) Haloperidol analogs and the use thereof
AU4732296A (en) Monolithic refactory and gunning material using the refactor y
AU7495796A (en) Novel oligopeptides, the preparation and use thereof
AU4279989A (en) Gasket and medical device using the same
AU6163590A (en) Mutant pseudorabies virus, and vaccines containing the same
AU7584191A (en) Compressed material and uses and methods for the use thereof
AU5836390A (en) Human lymphoma-associated virus